6 M), patients in the high-risk group showed a trend towards poorer prognosis compared to those in the low-risk group.
← all excerpts
IDH1<sup>R132H</sup> mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas.
1
—
—